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Interoffice Memorandum
SCHOOL OF PHARMACY
OFFICE OF THE DEAN
University, MS 38677
Phone: (662) 915-7265 Fax: (662) 915-5704
TO: All School of Pharmacy Personnel
FROM: Charles D. Hufford, Associate Dean for Research and Graduate Programs
DATE: October 28, 2002
SUBJECT: Research News (#3)
                                                                                                                                                                        
The following GRANTS/CONTRACTS have recently been awarded:
1. Dr. Mitchell Avery (P.I. – Medicinal Chemistry) – Development and Testing of New Medications
for the Treatment of Emerging Infectious Diseases (Center for Disease Control/National Institute for
Infectious Diseases) – $1,500,000.00 – September 15, 2002-September 14, 2003.
2. Dr. Mitchell Avery (P.I. – Medicinal Chemistry) – Development and Testing of New Antimalarial
Drugs (Department of Health and Human Services/Centers for Disease Control and Prevention) –
$2,499,996.00 – August 30, 2002-March 31, 2003.
3. Dr. John Bentley (P.I. – Pharmacy Administration) and Dr. Noel Wilkin (P.I. – Pharmacy
Administration) – The Medicare Prescription Continuity of Care Project: Development and
Implementation of the Prescription Continuity of Care System (Information and Quality Healthcare
– Mississippi’s Quality Improvement Organization) – $216,930.00 – July 1, 2002-June 30, 2003.
4. Dr. Joseph Byrd (P.I. – Pharmacy Practice) – Agreement for Teaching, Patient Care, and Clinical
Research Services (University of Mississippi Medical Center Department of Pediatrics) –
$22,008.00 – July 1, 2002-until amended.
5. Dr. Joseph Byrd (P.I. – Pharmacy Practice) – Agreement for Teaching, Patient Care, and Clinical
Research Services (University of Mississippi Internal Medicine Associates) – $9,000.00 – April 1,
2002-December 31, 2002.
6. Dr. Joseph Byrd (P.I. – Pharmacy Practice) – Administration and Operational Support for
Residency Training Programs (University Hospitals and Clinics) – $55,000.00 – July 1, 2002-June
30, 2003.
7. Dr. Joseph Byrd (P.I. – Pharmacy Practice) – Clinical and Administrative Services Contract
(University Hospitals and Clinics) – $155,000.00 - July 1, 2002-June 30, 2003.
8. Dr. Alice Clark (P.I. – RIPS/NCNPR) and Dr. Dale Nagle (Co-P.I. – Pharmacognosy) – New
Drugs for Opportunistic Infectious Diseases, Year 13 (National Institute of Allergy and Infectious
Diseases) – $251,125.00 – July 1, 2002-June 30, 2003.
9. Dr. John Cleary (P.I. – Pharmacy Practice) and Dr. Stanley Chapman (Co-P.I. – School of
Medicine) – A Trial of Zenapax â  (Daclizumab) for the Prevention of the Nephrotoxicity and Other
Adverse Reactions Associated with Amphotericin B Therapy in Fungal Disease (Roche
Pharmaceuticals) – $61,370.00 – September 11, 2002-September 11, 2006.
 
10. Dr. John Cleary (P.I. – Pharmacy Practice) – Pharmacogenomics of Natural Products with
Antifungal Activity (National Institute of Allergy and Infectious Diseases) – $288,151.00 – July 1,
2002-June 30, 2005.
11. Dr. Mahmoud ElSohly (P.I. – RIPS/NCNPR) and Dr. Samir Ross (Co-P.I. – RIPS/NCNPR) –
Production, Analysis and Distribution of Cannabis and Marijuana Cigarettes (Modification No. 7)
(National Institute on Drug Abuse) – $67,531.00.
12. Dr. Dennis Feller (P.I. – Pharmacology) and Dr. Ikhlas Khan (Co-P.I. – RIPS/NCNPR) – Effects
of Ephedra on Human Adrenoceptor Subtypes (National Center for Complementary and Alternative
Medicine) – $179,375.00 – September 1, 2002-August 31, 2003.
13. Dr. Mark Hamann (P.I. – Pharmacognosy) – Approaches to Characterization of Antiinfective
Agents (National Institute of Allergy and Infectious Diseases) – $101,250.00 – August 1, 2002-July
31, 2003.
14. Dr. Ikhlas Khan (P.I. – RIPS/NCNPR) – Mammalian Metabolism/Kinetics of Xanthohumol (Hop
Research Council) - $103,907.00 – June 1, 2002-May 31, 2003.
15. Dr. Christopher McCurdy (P.I. – Medicinal Chemistry) – Molecular Modeling, Design, Synthesis,
and Biological Evaluation of Novel Nociceptin/Orphanin FQ (N/OFQ) Receptor Ligands (American
Association of Colleges of Pharmacy New Investigators Program/American Foundation for
Pharmaceutical Education) - $10,000.
16. Dr. Larry Walker (P.I. – RIPS/NCNPR) – Natural Products Acting via New Anti-Fungal Targets
(Georgetown University/National Institutes of Health) – $303,715.00 - September 1, 2002-August
31, 2003.
17. Dr. Larry Walker (P.I. – RIPS/NCNPR) and Dr. Ikhlas Khan (Co-P.I. – RIPS/NCNPR) –
Botanical Dietary Supplements: Science-Base for Authentication and Analysis (Year 2) (Food and
Drug Administration) – $823,644.00 – September 30, 2002-September 29-2003.
18. Dr. Larry Walker (P.I. – RIPS/NCNPR) and Dr. Ikhlas Khan (Co-P.I. – RIPS/NCNPR) –
Botanical Dietary Supplements: Science-Base for Authentication and Analysis (Supplement) -
$667,356.00 – September 30, 2002-September 29, 2003.
19. Dr. Noel Wilkin (P.I. – Pharmacy Administration) and Dr. David McCaffrey (Co-P.I. –
Pharmacy Administration) – Evaluating the Relationships of Employee Loyalty, Customer Loyalty,
and Financial Performance in Community Pharmacies (Institute for the Advancement of
Community Pharmacy) – $7,500.00 – January 1, 2002-January 1, 2003.
20. Dr. Kristine Willett (P.I. – Pharmacology) – Characterization of Flavonoids’ Ability to Decrease
CYP1B1 Activity (American Association of Colleges of Pharmacy New Investigators
Program/American Foundation for Pharmaceutical Education) - $10,000.
21. Dr. John Williamson (P.I. – Medicinal Chemistry) – UM BRIP/UVI MBRS (University of the
Virgin Islands/NIH) – $9,500.00 – July 10, 2002.
22. Dr. John Williamson (P.I. – Medicinal Chemistry) and Ms. Jennifer Elzy (Co-P.I. -
Undergraduate Pharmacy Student) – Optimization of the Bioconversion of 10-Deoxaremisinin  by
Mucor ramannianus Using Fractional Factorial Methods: Illustration of How Whole-Cell Microbial
Transformations Can Be Integrated Into Organic Synthesis as Useful Reagents (American Society of
Pharmacognosy-Undergraduate Research Award) – $2,500.00.
The following PUBLICATIONS  have appeared:
1. A.J. Al-Rehaily, M.S. Ahmad, J.S. Mossa and I. Muhammad – “New Axane and Oppositane
Sesquiterpenes from Teclea nobilis”, Journal of Natural Products, pp. 1374-1376, 2002.
2. E. Bedir, I.A. Khan and L.A. Walker – “Biologically Active Steroidal Glycosides from Tribulus
terrestris”, Pharmazie, 57 , pp. 491-493, 2002.
3. W.G. Chambliss, C.D. Hufford, M.L. Flagg and J.K. Glisson – “Assessment of the Quality of
Reference Books on Botanical Dietary Supplements”, Journal of the American Pharmaceutical
Association, 42 , pp. 723-734, 2002.
4. W.M. Davis – “What Pharmacists Should Know About West Nile Virus – Newest Arbovirus to Cause
Encephalitis in the USA”, Bureau of Pharmaceutical Services web site, 2002.
5. D.C. Dunbar, J.M. Rimoldi, A.M. Clark, M. Kelly and M.T. Hamann – “Anti-Cryptococcal and
Nitric Oxide Synthase Inhibitory Imidazole Alkaloids from the Calcareous Sponge Leucetta cf
chagosensis”, Tetrahedron, 56 , pp. 8795-8798, 2000.
6. D. Ferreira and D. Slade – “Oligomeric Proanthocyanidins:  Naturally Occurring O-heterocycles”,
Nat. Prod. Rep., 19 , pp. 517-541, 2002.
7. D.D. Garner – “Effective Leadership: The Pharmacist’s Role and Responsibility”, Drug Topics, pp.
76-84, September 16, 2002.
8. T.R. Hoye, S.E.N. Ayyad, B.M. Eklov, N.E. Hashish, W.T. Shier, K.A. ElSayed and M.T. Hamann –
“Toward Computing Relative Configurations: 16-epi-Latrunculin B, a New Stereoisomer of the Actin
Polymerization Inhibitor Latrunculin B”, Journal of American Chemical Society, 124, pp. 7405-
7410, 2002.
9. Y. Luo, J.V. Smith, V. Paramasivam, A. Burdick, K.J. Curry, J.P. Buford, I.A. Khan, W.J. Netzer, H.
Xu and P. Butko – “Inhibition of Amyloid- b  Aggregation and Caspase-3 Activation by the Ginkgo
biloba Extract EGb761”, Proceedings of the National Academy of Sciences, pp. 12197-12202,
2002.
10. D.J. McCaffrey and D.D. Garner – “2001 Mississippi Compensation Survey”, Mississippi
Pharmacist, pp. 16-19, Summer 2002.
11. C.R. McCurdy – “Pharmacy Education: From Prescott to Pharmacogenomics”, Journal of the
American Pharmaceutical Association, 42 , pp. 688-691, 2002.
12. H. Mishra, A.L. Parrill and J.S. Williamson – “Three-Dimensional Quantitative Structure-
Activity Relationship and Comparative Molecular Field Analysis of Dipeptide Hydroxamic Acid
Helicobacter pylori Urease Inhibitors”, Antimicrobial Agents and Chemotherapy, 46 , pp. 2613-
2618, August 2002.
13. K.K. Schrader, D.G. Nagle and D.E. Wedge – “Algal and Cyanobacterial Metabolites as Agents
for Pest Management”, Advances in Microbial Toxin Research and its Biotechnological Exploitation,
pp. 171-195, 2002.
14. A.R. Spies – “Compounding: The Practice of Pharmacy or a Liability Risk?”, Drug Topics, pp. 36-
45, July 15, 2002.
15. S. Takamatsu, Q. Zhang, K.K. Schrader, H.N. ElSohly and L.A. Walker – “Characterization
of Mycotypha Metabolites Found to be Inhibitors of Cell Adhesion Molecules”, The Journal of
Antibiotics, 55 , pp. 585-592, June 2002.
16. R.L. Wood and E.H. Hood – “Management of Urinary Incontinence”, Drug Topics, pp. 53-62, June
2002.
17.  Z. Zhang, H.N. ElSohly, M.R. Jacob, D.S. Pasco, L.A. Walker and A.M. Clark – “New
Sesquiterpenoids from the Root of Guatteria multivenia”, Journal of Natural Products, 65 , pp. 856-
859, 2002.
18. Z. Zhang, H.N. ElSohly, M.R. Jacob, D.S. Pasco, L.A. Walker and A.M. Clark – “Natural
Products Inhibiting Candida albicans Secreted Aspartic Proteases from Lycopodium cernuum”,
Journal of Natural Products, 65 , pp. 979-985, 2002.
19. Z. Zhang, H.N. ElSohly, M.R. Jacob, D.S. Pasco, L.A. Walker and A.M. Clark – “Natural
Products Inhibiting Candida albicans Secreted Aspartic Proteases from Tovomita krukovii”, Planta
Med, 68 , pp. 49-54, 2002.
TECHNOLOGY TRANSFER  transactions:
In the interest of protecting confidential information, the names and titles associated with School of
Pharmacy invention disclosures and patent applications will no longer be published until after a patent has
issued.
Invention Disclosures Filed in 2002:  8
Patent Applications Pending: 11
Recent Patents Granted: N/A
Patents Recently Assigned to UM:
· Patent #: 6,375,963
“Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and
drug delivery and process for preparation thereof”
Michael Repka et. al.
· Patent #: 5,714,165
“Bioadhesive polyethylene glycol ointment for medicaments”
Michael Repka et. al
· Patent #: 5,112,620
“Polyethylene glycol ointment for apthous ulcers”
Michael Repka et. al
The following SPECIAL ANNOUNCEMENTS  are also listed:
·  Dr. Daneel Ferreira has been selected as President-elect for the Phytochemical Society of North
America for the period 2002-2003.
·  Mr. Scott Hicks was presented the 2002 Nobles Sam Award for his presentation entitled “Virtual High
Throughput Screening of Lead Analogs: Selection of a Focused Library of Inhibitors of Human Granzyme
B with Increased Potency”.  The award is presented each year to a Graduate Student in the Department
of Medicinal Chemistry.
·  The American Association of Colleges of Pharmacy recognized the outstanding accomplishments of 101
pharmacy educators from 63 U.S. colleges and schools of pharmacy during the AACP Annual Meeting
Awards Banquet on July 16, 2002 in Kansas City, Missouri.  Dr. Rachel Robinson was selected by
students and faculty to be honored as The University of Mississippi School of Pharmacy’s Outstanding
Teacher during the banquet.
·  The American Association of Colleges of Pharmacy installed its eleven-member Board of Directors on
July 17, 2002 at the conclusion of its 103rd Annual Meeting.  Dean Barbara G. Wells was installed as
the President and Chairman of the Board of Directors.
·  Mr. Francis Tukov (Pharmacology Graduate Student) was awarded the first place award and Mr. Ruben
Salas (Visiting Scholar) was awarded the second place award for their poster presentations at the recent
Southeastern Pharmacology Meeting, which was held in Johnson City, Tennessee.
Please continue to send me important research and graduate information so that I might share it with your
faculty colleagues.  THIS INFORMATION IS NOW BEING POSTED ON THE SCHOOL OF
PHARMACY WEB PAGE!  Thank you.
cc: Dean Barbara G. Wells
Ms. Dabney Weems
